Generic Version of Neupro Patch Soon to Enter Testing

Manufacturing will soon begin on a generic version of the Neupro patch, a transdermal delivery system for rotigotine — a dopamine agonist — to treat Parkinson’s symptoms, Vektor Pharma announced in a press release. Testing of its rotigotine patches will first take place at Vektor’s laboratories in Germany, before quickly moving into…

Generic Rotigotine Patches Developed by Vektor Pharma

A generic version of the transdermal (absorbed through the skin) Neupro patch (rotigotine), often used to ease the symptoms of Parkinson’s disease, has been developed by Vektor Pharma. …